Published: June 17, 2020 23:22:54 | Updated: June 22, 2020 21:58:20
A pharmacist displays a box of Hydroxychloroquine at the CHR Centre Hospitalier Regional de la Citadelle Hospital amid the coronavirus disease (COVID-19) in Liege, Belgium, June 16, 2020. Reuters
The World Health Organisation said on Wednesday that testing of the malaria drug hydroxychloroquine in its large multi-country trial of treatments for COVID-19 patients had been halted after results from other trials showed no benefit, reports Reuters.
"The hydroxychloroquine arm of the SOLIDARITY trial has been stopped," WHO expert Ana Maria Henao-Restrepo told a news briefing.
Moderna to make milestone payments to US for Covid-19 vaccine
Bird flu situation 'worrying', WHO working with Cambodia
A woman dies every two minutes due to pregnancy or childbirth: UN report
Oral dose of azithromycin at normal birth can reduce 33pc maternal sepsis and deaths: Study
Can topical treatment alone fix acne scars?
Vitamin A-plus campaign for 22.0 million children held
Why the success of making an artificial heart remains elusive?
No specific research on zinc level in rice
© 2024 - All Rights with The Financial Express
